Replies to post #393507 on Innovation Pharmaceuticals Inc (IPIX)

[bradfordbros]

The CEO of Ipix is Leo Ehrlich and he will remain the CEO until he isn't. As somebody who has been around for so long what do think? We'll suddenly get a new CEO? No, I didn't think so.

[steelyeye]

There have been lots of disparaging arguments directed at CEO Ehrlich, including ones that harp on the company being suspect because merely a "one man band."

I suspect Leo has been working on the annual report, while also interacting with NIAID, NIH and the Military, getting ready for the conference last week, and perhaps taking calls of interest from Pharmas. The "very easy" recertification in Nevada shouldn't be hard to correct, once the very busy CEO gets to it (just ask Mrs. Ehrlich).

Demanding to know "at this moment" about the readiness of the annual report, who is in it, and the temporary lapse of good standing, won't make the information available any sooner, so we'll all have to wait a few days more. We'll also find out about any hypothetical "default standing" which actually doesn't seem to have affected shares trading in a "marketplace" that is not a real "exchange."

Let us know if an NT gets filed. It sometimes happens to small companies who are "one man bands" with lots on their plate. Unless the belief is that Leo is still poolside sipping a drink?

Funny thing is, all is forgiven if one or more deals get struck, or funding is obtained. Do you think that might happen in the next month or two?

Are there any questions about the number of viruses Brilacidin effectively inhibits in vitro?

Any idea if the military has been quietly testing the drug?

This post is in response to:

As of this moment has the Annual Report due on 8/31/21 been filed and will that be adequate to allow for the restoration of an Active status? Or willl the Company still be in Default based on the Annual Report due on 8/31/22 (and already late)?

[steelyeye]

The tone of these questions for CEO Ehrlich sound rather demanding and demeaning, and we're all waiting to see if answers are forthcoming. Can you provide any "at this moment"? Or are we all simply waiting for the 10K?
You wouldn't want anyone to disclose non-public information in advance, would you?

Why wasn't the Annual Report filing made on a timely basis...a full year and 3 weeks ago?

Given that the State of Nevada website stills says "INNOVATION PHARMACEUTICALS INC. Revoked" what do you mean by "The Nevada filing has been addressed"?

As of this moment has the Annual Report due on 8/31/21 been filed and will that be adequate to allow for the restoration of an Active status? Or willl the Company still be in Default based on the Annual Report due on 8/31/22 (and already late)?

Are both Drs. Schechter and Spektor listed as Directors in the Report? (Asking because the latter ISN'T listed in the Florida filing.)
Did the lack of good standing in Nevada result in the removal of IPIX from the OTCQB tier or was it something else?